Stockscreener 앱 받기
4.695
2.39%
-0.115
시간 외 거래:
4.75
0.055
+1.17%
Unicycive Therapeutics Inc 주식(UNCY)의 최신 뉴스
Faruqi & Faruqi, LLP Urges Unicycive Therapeutics, Inc. (UNCY) Investors to Seek Counsel Before the November 2, 2026 Lead Plaintiff Deadline in the Securities Class Action - TMX Newsfile
Shareholders of Unicycive Therapeutics, Inc. (UNCY): Protect Your Rights Before November 2, 2026 – Contact Levi & Korsinsky - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionUNCY - TMX Newsfile
UNCY Stockholders Have Rights – If You Lost Money Investing - GlobeNewswire
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval - Stocktwits
UNCY Stock Crashed 45% Today – Why Did FDA Reject Its Kidney Disease NDA For A Second Time? - Stocktwits
Levi & Korsinsky Urges Unicycive Therapeutics, Inc. (UNCY) Shareholders to Act Before Lead Plaintiff Deadline November 2, 2026 - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of November 2, 2026 Deadline - ACCESS Newswire
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Before November 2, 2026Contact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Over Securities ViolationsContact Levi & Korsinsky Today - accessnewswire.com
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Deadline on November 2, 2026 - The Globe and Mail
Bronstein, Gewirtz & Grossman LLC Urges Unicycive - GlobeNewswire
UNCY Shareholder Alert: November 2, 2026 Lead Plaintiff Deadline in Unicycive Therapeutics, Inc. Securities Class ActionContact SueWallSt - PR Newswire
Securities Class Action Lawsuit Filed Against Unicycive Therapeutics, Inc. (UNCY)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
UNCY Investor Alert: Unicycive Therapeutics, Inc. Securities Class Action NoticeContact Levi & Korsinsky - AOL.ca
Did You Lose Money on Unicycive Therapeutics, Inc. (UNCY)? Levi & Korsinsky Urges Investors to Act Before November 2, 2026 - ACCESS Newswire
UNCY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Unicyci - The National Law Review
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Unicycive - GlobeNewswire
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 2, 2026 - NewMediaWire
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) - The National Law Review
UNCY stock rises after a class action filing and a reverse split - ad-hoc-news.de
Deadline Alert: Unicycive Therapeutics, Inc. (UNCY) - GlobeNewswire
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. (UNCY) Shareholders of Class Action Lawsuit and November 2, 2026 Deadline - ACCESS Newswire
Unicycive Therapeutics, Inc.(NasdaqCM: UNCY) added to S&P Global BMI Index - marketscreener.com
UNCY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Unicycive Therapeutics stock holds at USD 4.80 - AD HOC NEWS
UNCY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026 - TMX Newsfile
Securities Lawsuit Alert: Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky Before November 2, 2026 - ACCESS Newswire
UNCY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Robbins LLP Urges UNCY Stockholders Who Lost Money Investing in Unicycive Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action - Business Wire
Contact Levi & Korsinsky by November 2, 2026 to Join Class Action Against Unicycive Therapeutics, Inc. (UNCY) - ACCESS Newswire
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
UNCY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
ROSEN, A LEADING NATIONAL FIRM, Encourages Unicycive - GlobeNewswire
DEADLINE ALERT for YSS, HIMS, UNCY, and PZZA: The Law - GlobeNewswire
UNCY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026 - TMX Newsfile
Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) Profit Outlook - simplywall.st
Unicycive Therapeutics stock faces class action pressure after manufacturing oversight claims - AD HOC NEWS
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Unicycive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - WBOC TV
UNCY Shareholder Alert: Unicycive Therapeutics, Inc. Securities Class Action LawsuitInvestors Should Contact SueWallSt - PR Newswire
Kirby McInerney LLP Alerts Investors Who Acquired Unicycive - GlobeNewswire
UNCY DEADLINE: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire
UNCY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionUNCY - conwaydailysun.com
UNCY: Regulatory approval awaits only a vendor inspection, with launch readiness and funding secured - TradingView
Robbins LLP is Investigating Allegations that Unicycive Therapeutics, Inc. Failed to Properly Inspect its Third-Party Vendor's Manufacturing Facility to Ensure it Resolved the FDA's Previously Noted Deficiencies - The Globe and Mail
Class Action Lawsuit Filed Against Unicycive Therapeutics, Inc. (UNCY)Recover LossesContact Levi & Korsinsky Before November 2, 2026 - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
ETFs Investing in Unicycive Therapeutics, Inc. Stocks - TradingView
Class Action Lawsuit Filed: Unicycive Therapeutics, Inc. (UNCY) – Join by November 2, 2026 – Contact Levi & Korsinsky - ACCESS Newswire
Unicycive Therapeutics, Inc. (UNCY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 2, 2026 Deadline - ACCESS Newswire
ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages - GlobeNewswire
ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Levi & Korsinsky Reminds Unicycive Therapeutics Investors of the - The National Law Review
Levi & Korsinsky Reminds Unicycive Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 2, 2026UNCY - Business Wire
UNCY Class Action Notice: Robbins LLP Reminds Investors of - GlobeNewswire
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to Contact the Firm to Learn About Their Legal Rights - NewMediaWire
UNCY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Unicycive Therapeutics Securities LawsuitContact SueWallSt - PR Newswire
Portnoy Law Firm Announces Class Action on Behalf of Unicycive Therapeutics, Inc. Investors - GlobeNewswire
3.06%
2.55%
자본화:
|
볼륨(24시간):